Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Clin Pharmacol Ther. 2022 Sep 24;113(5):973–985. doi: 10.1002/cpt.2735

Table 1.

Assignment of predicted G6PD phenotype based on genotype

Predicted phenotype Genotypea Examples of G6PD genotypesb
Normal A person with one X chromosome carrying a non-deficient (class IV) allele
A person carrying two non-deficient (class IV) alleles
B, Sao Boria, IV
B/B, B/Sao Boria, B/A, IV/IV
Deficient A person with one X chromosome carrying a deficient (class II-III) allele
A person carrying two deficient (class II-III) alleles OR one class I allele and one class II or III allele
A-, Orissa, Kalyan-Kerala, Mediterranean, Canton, Chatham, II, III
A-/A-, A-/Orissa, Orissa/ Kalyan-Kerala, Mediterranean/ Mediterranean, Chatham /Mediterranean, Canton/ Viangchan, II/II, II/III, III/III, I/II, I/III
Deficient with CNSHA A person with one X chromosome carrying a deficient (class I) allele
A person carrying two deficient (class I) allelesd
Bangkok, Villeurbanne, I
Bangkok/Bangkok, Bangkok/Villeurbanne, I/I
Variablec A person carrying one non-deficient (class IV) allele and one deficient (class I-III) allele B /Bangkok, B/Mediterranean, B/A-, IV/I, IV/II, IV/III

CNSHA, chronic non-spherocytic hemolytic anemia; G6PD, glucose-6-phosphate dehydrogenase; WHO, World Health Organization

a

WHO classifications from (8), other details from (14). Class I alleles are extremely rare; the distinction between Class II and III alleles is not clear. Almost all patients will carry class II, III, or IV alleles.

b

Due to the large number of G6PD alleles, other genotypes may be possible besides those given as examples here; see the G6PD Allele Definition Table (5, 6) for a more comprehensive list of alleles and G6PD Allele Functionality Table (5, 6) for their assigned function (WHO class). Note that some labs use the designation “B allele” to indicate an allele carrying no known class I-III variants. The G6PD Frequency Table (5, 6) can be referenced for the frequency of G6PD alleles across major biogeographical groups.

c

Due to X-linked mosaicism, persons heterozygous (generally females) for one non-deficient (class IV) and one deficient (class I-III alleles) allele may display a normal or a deficient phenotype. It is therefore difficult to predict the phenotype of these individuals (see Supplement, G6PD Heterozygotes).

d

Such genotypes have never been seen and are presumably exceedingly rare.